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Plasma membrane Ca2+-ATPase activity diminishes by about 50% in red blood cells during preeclampsia. We investigated whether the number
of Ca2+-ATPase molecules is modified in red cell membranes from preeclamptic pregnant women by measuring the specific phosphorylated
intermediate of this enzyme. Also, we isolated the Ca2+-ATPase protein from both normotensive and preeclamptic pregnant women and estimated
its molecular weight, and its cross-reactions with specific polyclonal and monoclonal (5F10) antibodies against it. We measured the Ca2+-ATPase
activity in a purified state and the effect of known modulators of this ATPase. It was found that the phosphorylated intermediate associated with
PMCA is similar for red cell ghosts from normotensive and preeclamptic women, suggesting a similar number of ATPase molecules in these
membranes. The molecular weight of the Ca2+-ATPase is around 140 kDa for both normotensive and preeclamptic membranes, and its cross-
reactions with specific antibodies is similar, suggesting that the protein structure remains intact in preeclampsia. Calmodulin, ethanol, or both
calmodulin plus ethanol, stimulated the Ca2+-ATPase activity to the same extent for both normotensive and preeclamptic preparations. Our results
showed that the reduced Ca2+-ATPase activity of the red cell membranes from preeclamptic women is not associated with a defective enzyme, but
rather with a high level of lipid peroxidation.
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Preeclampsia is an important complication that can develop
during pregnancy after the 20th week of gestation and affects
approximately 7% to 10% of pregnant women. It is character-
ized by generalized arteriolar vasospasm, abnormalities inAbbreviations: PMCA, plasma membrane calcium-stimulated adenosine
triphosphatase; EDTA, ethylenediamine tetraacetic acid; EGTA, ethylene
glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid; MDA, malondialde-
hyde; TBARS, thiobarbituric acid-reactive substances
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doi:10.1016/j.bbadis.2005.12.001plasma volume, high blood pressure and proteinuria, and might
occasionally be accompanied by renal failure, stroke, liver
failure, pulmonary edema, and coagulopathy. The disease can
progress to eclampsia (seizures) and it is indeed a very
important cause of morbidity and mortality among pregnant
women and fetuses [1].
Although the etiology of preeclampsia remains unknown,
there is growing evidence that placental ischemia plays a causal
role in the elevated blood pressure, which typically resolves
rapidly following delivery [2]. The placental ischemia could
promote lipid peroxidation reactions [3,4] and their byproducts
have been reported to be elevated in the serum of preeclamptic
women [5,6]. Circulating blood cells, such as erythrocytes and
platelets, could be oxidized during transit through the placenta,
propagating in this way the lipid peroxidation at sites distal to
Table 1
Clinical data from 60 healthy pregnant women (normotensives) and 60 pregnant
women with severe preeclampsia
Patients Normotensives Preeclamptics





BMI (kg/m2) 30.1±0.8 31.7±0.9
Gestational age (wk) 38.7±0.5 37.3±0.5
Systolic blood pressure (mm Hg) 112.9±4.2 172.5±5.6 ⁎
Diastolic blood pressure (mm Hg) 67.8±3.8 113.9±2.4 ⁎
Protein excretion (g/24 h) 0.15±0.06 5.77±0.45 ⁎
Oliguria (number of women) 0 60
Preexistent renal disease 0 0
Diabetes mellitus 0 0
Values are means±S.E.
⁎ Pb0.001 (vs. normotensives).
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membranes [3], lipid peroxidation could decrease membrane
fluidity and thereby could reduce the activity of membrane
enzymes, such as the PMCA [7]. In fact, we have previously
shown that the PMCA activity of maternal and neonatal red cell
ghosts [8,9], myometrium [4] and syncytiotrophoblast basal
(fetal-facing) plasma membranes [10,11] of preeclamptic
pregnant women, is reduced in about 50% as compared to the
ATPase activity of the same tissues from normotensive pregnant
women. Since these membranes show higher levels of lipid
peroxidation, it has been suggested that this process is
responsible for the diminution of PMCA activity in pre-
eclampsia [7]. However, modifications on the protein structure
of the ATPase could also drive to inhibition of its activity. In
the present work, we isolated and purified the PMCA protein
of red blood cell membranes from both normotensive and
preeclamptic pregnant women, in order to study if this ATPase
is defective in this illness. It was found that the red cell
membrane PMCA protein is not affected by preeclampsia and
the diminution in the activity of this enzyme in this disease is
related to an enhanced level of lipid peroxidation of the plasma
membranes.
2. Materials and methods
2.1. Blood donors
Sixty normotensive and sixty severe preeclamptic pregnant women of the
Maternity Hospital “Concepción Palacios” in Caracas, participated in this study
in accordance with the ethical standards established by the Declaration of
Helsinki. The study protocol was approved by the Institutional Review Board of
the Maternity “Concepción Palacios” and by the Bioethics Committee of IVIC,
and all women gave informed signed consent. The study was performed at
admission, before any medical treatment, and before delivery. All the women
had similar demographic backgrounds, and belonged to urban population of
Caracas. Gestational age was estimated from the date of the last menstrual period
and confirmed by ultrasonography. Normotensive pregnant women had no
history of hypertension and no evidence of hypertension or proteinuria during
their pregnancy. The pregnant women with severe preeclampsia were defined by
detection of proteinuria (N5 g/day), a blood pressure N160/110 mm Hg, oliguria(≤500 ml/24 h), headache and epigastric pain. The blood pressure was measured
twice, 6 h apart at bed rest; the diastolic level was measured at Korotkoff phase
V. Any woman that, according to her medical history, was under medical
treatment to control blood pressure, or if she was taking N1 g of elemental
calcium per day during pregnancy, or if she had a history of chronic
hypertension, diabetes, calcium metabolism disorders, or any other chronic
medical illness, was not considered for this study. Only women giving birth a
single newborn with Apgar scores of 7–10 were included. The clinical data of
normotensive and preeclamptic pregnant women are presented in Table 1.
Ten ml of venous blood were collected into heparinized collection tubes
from either normotensive or preeclamptic pregnant women before delivery
(antepartum). Blood samples were obtained by venipuncture with the patients in
lateral decubitus position and immediately transported to our laboratory on ice.
Each blood sample was centrifuged at 12,000×g for 1 min at 4 °C and the buffy
coat and the plasma were discarded. Hemoglobin-free red blood cell ghosts were
prepared from the packed red blood cells, following a modification of the
method of Heinz and Hoffman [12]. Briefly, the packed red blood cells were
hemolyzed (10:1) in a solution containing 10 mM Tris–HCl, 1 mM EDTA (pH
7.5 at 0 °C), and 5 mM phenyl methyl sulfonyl fluoride. Then the ghosts were
washed twice with a solution of 10 mM HEPES–KOH, and stored in a solution
containing 130 mMKCI, 10 mMHEPES/KOH, pH 7.4, 0.5 mMMgCl2, and 50
μM CaCl2, and kept at −70 °C until use.
2.2. Purification of the erythrocyte PMCA by calmodulin affinity
chromatography
The procedure described by Benaim et al. [13] was followed. Red cell ghosts
pooled from either 20 normotensive pregnant women or 20 preeclamptic
pregnant women were used (150–250 mg of ghost protein). Briefly, red cell
ghosts (5 mg/ml) were solubilized on ice for 10 min by adding 1 mg of Triton X-
100/mg of protein. Nonsolubilized material was removed by centrifugation at
100,000×g at 2 °C for 35 min. Phosphatidylcholine and CaCl2, were then added
to the supernatant to final concentrations of 0.5 mg/ml and 100 μM, respectively,
and the mixture was applied to a calmodulin-Sepharose 4B column (3–4 ml bed
volume), which was equilibrated in a buffer containing 0.4% (w/v) Triton X-
100, 130 mMKCl, 20 mMHEPES/KOH, pH 7.4, 1 mMMgCl2, 100 μMCaCl2,
2 mM dithiothreitol, and 0.5 mg/ml of phosphatidylcholine. The column was
loaded and washed at a rate of about 40–50 ml/h. The column was then washed
with 40 ml of the equilibration buffer and with 40 ml of a similar buffer
containing 0.05% instead of 0.4% Triton X-100 and Na+ instead of K+. Finally,
the purified PMCAwas eluted in a buffer containing 0.05% (w/v) Triton X-100,
130 mMNaCl, 20 mMHEPES/NaOH, pH 7.4, 1 mMMgC12, 2 mMNa-EDTA,
2 mM dithiothreitol, 5% glycerol (v/v), and 0.5 mg/ml of phosphatidylcholine.
Na+ was substituted for K+ to avoid SDS precipitation in the preparation of
samples for SDS-polyacrylamide gel electrophoresis. 0.15–0.25 mg of purified
erythrocyte PMCA (concentration about 0.1–0.2 mg/ml) was routinely
obtained. The EDTA contained in the active fractions eluted from the column
was neutralized by the addition of MgCl2 to a final concentration of 2 mM.
CaCl2 was added to a final concentration of 50 μM. The purified ATPase was
stored under N2 atmosphere at −80 °C.
2.3. ATPase assays
Aliquots of purified PMCA (about 1–2 μg of protein/ml) were incubated in a
medium containing 130 mM KCl, 20 mM HEPES/KOH, pH 7.2, 1 mM ATP, 1
mMMgCl2, 1 mM EGTA and the appropriate concentrations of CaCl2 to obtain
the desired free calcium concentration. The final concentration of calcium ions
was calculated by using an iterative computer program as described previously
[14]. Since the rates of ATPase activity were linear over 45 min incubation at
37 °C, the reaction was arrested at 45 min by the addition of 8% (final
concentration) cold trichloroacetic acid. When ghost preparations were used, the
mixture was centrifuged and the supernatant was kept for inorganic phosphate
determination. The latter was carried out according the colorimetric method of
Fiske and SubbaRow [15], modified by the use of FeSO4 as reducing agent. A
coupled-enzyme assay system was used to measure the PMCA activity during
purification of the enzyme, as described previously [16]. The medium contained
10 μM free Ca2+, 120 mM KCl, 30 mM HEPES/KOH, pH 7.4, 2.5 mM MgCl2,
Table 2
Effect of 0.1 μM calmodulin and 5% ethanol on the PMCA activity of red cell
ghosts from normotensive and preeclamptic pregnant women
Addition Normotensive % Stimulation Preeclamptic % Stimulation
None 19.63±0.69 – 8.39±0.45 –
calmodulin 25.55±0.47 ⁎ 30.0 10.96±0.32 ⁎ 30.6
ethanol 26.03±0.65 ⁎ 32.6 11.32±0.56 ⁎ 34.9
calmodulin+
ethanol
32.12±0.80 ⁎, a 63.6 14.69±0.64 ⁎, a 75.0
ATPase activity is expressed as nmol Pi×mg prot−1×min−1. Values are
means±S.E. of determinations carried out with different preparations from
different women (n=60).
a Pb0.001 (vs. either calmodulin or ethanol).
⁎ Pb0.001 (vs. no addition).
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kinase and 1 unit of lactic dehydrogenase, and the reaction was monitored at 37
°C in a final volume of 1 ml. The difference in absorbance between 366 and 550
nm was plotted versus time using a dual-wavelength spectrophotometer (SLM
Aminco DW-2000). The PMCA activity was calculated as the difference
between the amount of phosphate liberated in the tubes containing Ca2+ minus
that liberated in the tubes without Ca2+. The results are expressed as nanomoles
of inorganic phosphate liberated per milligram of protein per minute, after
subtraction of a blank run in parallel without the membrane suspension, which
was added after the addition of the trichloroacetic acid.
2.4. SDS-polyacrylamide gel electrophoresis and Western blot
analysis
Proteins were separated on SDS-polyacrylamide gel electrophoresis accord-
ing to Laemmli [17]. They were transferred to 45 μm nitrocellulose membranes
(Immobilon-NC-Haft-Nitrocelulose, Sigma) [18] and blocked for 2 h with 3%
gelatin from pig skin in TBS (10mMTris–HCl, pH 7.0, 500mMNaCl) followed
by a wash for 5 min in TBS and two washes for 5 min each in TBS-T
(TBS+0.05% Tween-20). The membrane was then incubated with the primary
antibody (diluted 1/1000) in TBS-T plus 1% gelatin from pig skin) for 90 min.
Two different primary antibodies against the PMCA from human red blood cells
were used: a polyclonal antibody prepared in our laboratory and a commercially
available monoclonal antibody (5F10, Sigma). The membrane was then washed
3 times for 5 min with TBS-T. The incubation with the secondary antibody
(alkaline phosphatase coupled to an anti-rabbit or anti-mouse antibody;
Promega Corp., Madison, WI) and the staining were performed according to
the manufacturer's protocol (ProtoBlot AP, Promega Corp.).
2.5. Formation of the PMCA phosphoenzyme intermediate
The phosphoenzyme intermediate of the PMCA was measured by a
modification of the method described by Knauf et al. [19]. In brief, 40 μl of red
cells ghosts (2 mg/ml protein) were added to the incubation medium containing
(final concentrations): 12 μMMgCl2; 30 mM Tris–HCl (pH 7.4 at 0 °C); 12 μM
ATP with traces of [γ-32P] ATP, with a specific activity of 1 mCi/100 ml and less
than 0.1% hydrolysis (Amersham, Inc.) and according to the experimental
needs, 125 μMCaCl2. The assay was carried out at 0 °C and it was stopped after
1 min by the addition of 400 μl of ice-cold 5% (w/v) trichloroacetic acid
containing 0.1 mM ATP and 1 mM Pi (as orthophosphoric acid). The denatured
proteins were collected by centrifugation (16,000×g) for 2 min and washed
twice with the above solution. The final precipitates were dissolved with 500 μl
of 0.2% Triton X100. The suspension was transferred to scintillation vials
containing 4.5 ml of instagel and the radioactivity was measured in a beta
counter (LKBWallac, Rackbeta, Liquid Scintillation Counter, model 1217). The
phosphorylated intermediate is expressed as picomoles of phosphorus per
milligram of protein.
2.6. Lipid peroxidation measurements
The amount of lipid peroxidation of the red blood cell ghosts was estimated
by measuring the thiobarbituric acid-reactive substances (TBARS), carried out
following the method of Feix et al. [20]. The absorbance was measured at 532
nm and the thiobarbituric acid-reactive substances values were calculated by use
of a malondialdehyde standard curve prepared by acid hydrolysis of 1,1,3,3-
tetramethoxypropane. The TBARS are expressed as nanomoles of malondial-
dehyde per milligram of protein. Total lipids were extracted from red blood cell
ghosts according to the method of Folch et al. [21].
2.7. Statistical analysis
Statistical analysis was performed by the Student's t test. All results are
expressed as means±S.E. and (n) represents the number of experiments
performed with different preparations. Each preparation was assayed in
quadruplicate for all determinations. The PMCA activity was calculated from
paired data. A P value ≤0.05 was accepted as statistically significant.3. Results
As already described [8,9], and now shown in Table 2, the
PMCA activity of red cell ghosts from preeclamptic women
without any treatment is lower than that of normotensive
pregnant women. However, the stimulating effect of
calmodulin and ethanol, two well-known stimulators of the
PMCA [22], was similar for both preparations, reaching in
both cases a stimulation of about 30%. Also similarly, the
stimulating effects of calmodulin and ethanol showed to be
additive.
The level of lipid peroxidation of red cell ghosts, as assessed
by TBARS and conjugated dienes, is higher for the preeclamp-
tic women without any treatment. TBARS changed from
0.41±0.07 nmol MDA/mg protein for normotensives to
0.91 ± 0.09 nmol MDA/mg protein for preeclamptics
(Pb0.001). On the other hand, the conjugated dienes changed
from 1.44±0.16 nmol hydroperoxides/mg lipids for normoten-
sives to 2.14±0.10 nmol hydroperoxides/mg lipids for
preeclamptics (Pb0.001).
Regardless of the higher level of lipid peroxidation of the red
cell ghosts of the preeclamptic women, direct modifications of
the PMCA protein – involving a diminution in the number of
functional protein and/or structural changes – could explain the
enzyme-decreased activity observed with this disease. To study
this possibility, we carried out two different kind of experi-
ments: (1) determination of the PMCA phosphoenzyme
intermediate for both red cell ghosts from normotensive and
preeclamptic pregnant women and (2) purification of the PMCA
protein of red cell ghosts from either normotensive or
preeclamptic pregnant women, in order to determine their
activities and to test the effects of calmodulin and ethanol on
both preparations.
The level of PMCA phosphoenzyme intermediate is quite
similar for both normotensive (1.59±0.08 pmol P/mg protein)
and preeclamptic women (1.67±0.09 pmol P/mg protein),
suggesting a similar number of ATPase molecules in the red cell
membranes.
The percentage of recovery of the purified fraction of PMCA
of red cell ghosts from normotensive (0.090±0.011%) and
preeclamptic pregnant women (0.103±0.003%) is similar. The
electrophoretic patterns of the proteins of these preparations of
Table 3
Effect of 0.1 μM calmodulin and 5% ethanol on the activity of purified PMCA
of red cell ghosts from normotensive and preeclamptic pregnant women
Addition Normotensive Preeclamptic
None 1.24±0.15 1.17±0.08
Calmodulin 1.85±0.15 ⁎ 1.83±0.12 ⁎
Ethanol 1.86±0.09 ⁎ 1.91±0.09 a
Calmodulin+ethanol 2.83±0.15 a, b 2.87±0.18 a, b
ATPase activity is expressed as μmol Pi×mg prot−1 min−1. Values are
means±S.E. of determinations carried out with different purified fractions
obtained from pools of red cell ghosts from 20 different women (n=3).
a Pb0.01 (vs. no addition).
b Pb0.01 (vs. either calmodulin or ethanol).
⁎ Pb0.05 (vs. no addition).
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preparations are quite similar, showing a main peak around 140
kDa, which is in agreement with the molecular weight of the
PMCA [23]. There is also a second peak, which has been
previously seen with similar preparations and it has been
suggested to be part of the active PMCA [24]. The structural
integrity of the purified preparations of PMCAwas assessed by
testing the cross reactions with specific polyclonal and
monoclonal (5F10) antibodies against the PMCA. For both
samples, the PMCA-specific band at around 140 kDa became
evident in Western blotting stained with the 5F10 or a
polyclonal antibodies specific for the PMCA (data not shown).
The stimulatory effects of calmodulin and ethanol on the
pure preparations of PMCA of both samples were tested. The
results of these experiments are shown in Table 3. It can be seen
that either calmodulin, ethanol or both calmodulin plus ethanol,
stimulated the PMCA activity to the same extent for both
normotensive and preeclamptic preparations.
4. Discussion
The present study was carried out in order to evaluate the
possibility of a defect of the PMCA protein itself or a
reduction in the number of ATPase molecules, besides theFig. 1. Electrophoretic pattern and its densitometric scan of purified fractions of
red cell ghosts from normotensive and preeclamptic pregnant women.
Standards: myosin (200 kDa), β-galactosidase (116.2 kDa), phosphorylase b
(92.5 kDa), bovine serum albumin (66.2 kDa).increased plasma membrane lipid peroxidation during pre-
eclampsia. The facts that the amount of PMCA phosphoen-
zyme intermediate is similar for the red cell ghosts from
normotensive and preeclamptic pregnant women, and that the
ATPase activities are similar for both samples after purifica-
tion and resuspension of the protein (Table 3), clearly indicate
that the number of PMCA molecules of the red cell membrane
does not change in preeclampsia. On the other hand, the
PMCA protein does not seem to be modified in the red cell
membranes of preeclamptic pregnant women. This conclusion
is based on the following evidences: (1) the activities of the
membranes or the purified ATPases from normotensive or
preeclamptic women are stimulated by calmodulin, ethanol or
ethanol plus calmodulin in a similar proportion (Table 3); (2)
preeclampsia does not modify the Km for Ca
2+, optimal pH
and temperature of the PMCA [7]; and (3) the molecular
weight of the PMCA (Fig. 1) and the cross reactions with
specific polyclonal and monoclonal (5F10) antibodies against
the PMCA are similar for both purified preparations of
PMCA, either from normotensive or from preeclamptic
pregnant women. Therefore, the diminution of PMCA activity
in preeclampsia may be considered to be the result of the high
level of lipid peroxidation of the cell tissues of the
preeclamptic women. This condition, by producing modifica-
tions in the protein–lipid interactions, might affect directly the
activity of the PMCA. Further support for a causal relationship
between lipid peroxidation of red cell membranes and PMCA
activity in preeclampsia, is provided by the finding that both,
lipid peroxidation of the red cell membrane and PMCA
activity, return to normal values when all the symptoms of
preeclampsia disappear in the postpartum [25].
The PMCA is a crucial enzyme for the cytoplasmic control of
cell calcium. The impaired function of the PMCA in
preeclampsia can disrupt the maintenance of appropriate Ca2+
gradients, leading to cellular dysfunction. Thus, an enhanced
concentration of cytoplasmic Ca2+ in the vascular smooth
muscle cells could increase muscle tension, resulting in
vasoconstriction and, consequently, hypertension. Interestingly,
alterations in smooth muscle Ca2+ regulation in preeclampsia
have been previously reported [26–28]. Therapeutic treatments –
such as antioxidants – leading to protection of PMCA protein–
lipid interactions may help to regulate some of the symptoms of
this pathology.
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